ARANZ Medical Launches Two New Silhouette Image Capture Products


CHRISTCHURCH, New ZealandMarch 28, 2018 /PRNewswire/ — Two new smart-phone based imaging products, SilhouetteLite+ and SilhouetteLite, recently launched by ARANZ Medical Limited have been adopted by Promore Pharma AB (Solna, Sweden) for a multi-site clinical trial, and by New Zealand’s Capital and Coast District Health Board for their community-based nurses.

Easy-to-use, SilhouetteLite+ and SilhouetteLite apps are highly portable, yet deliver robust accuracy and image consistency. The measurement and documentation data collected is securely synchronized in ARANZ Medical’s proprietary, cloud database, SilhouetteCentral, for ease of analysis and reporting.


Promore Pharma purchased 20 SilhouetteLite+ units for their two-year venous leg ulcer study. Chief Scientific Officer, Dr. Margit Mahlapuu, stated, “The SilhouetteLite+ app and documentation system is easy for us to use across multiple locations. With it, we can ensure that the data we collect at each site is not only consistent and secure, but also easily accessed for analysis and reporting.”

read more